A study on effects of three feeding regimens in promoting recovery in children with uncomplicated Severe Acute Malnutrition (SAM)
Not Applicable
Active, not recruiting
- Conditions
- Health Condition 1: null- Uncomplicated severe acute malnutrition
- Registration Number
- CTRI/2012/10/003054
- Lead Sponsor
- ita Bhandari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 911
Inclusion Criteria
Age 6 to 59 months
- SAM, defined as Weight for height less than -3 SD of WHO standard or oedema of both feet, or both.
Exclusion Criteria
- Complicated SAM defined as child with SAM having signs of severe illness requiring hospitalization
- Known allergy to animal milk or peanuts
- Likely to leave the study area permanently in the next 16 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recovery by 16 weeks after enrolment (defined as achieving WFH greater than or equal to -2 SD and absence of oedema of both feet)Timepoint: Enrolment to 16 weeks
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie recovery in uncomplicated severe acute malnutrition (SAM) patients treated with different feeding regimens in CTRI/2012/10/003054?
How do the three feeding regimens in CTRI/2012/10/003054 compare to standard-of-care for uncomplicated SAM in terms of efficacy and nutritional outcomes?
What biomarkers correlate with successful recovery in children with uncomplicated SAM receiving varied feeding protocols in the SAMPOORNA trial?
What are the potential adverse events associated with high-protein versus standard feeding approaches in CTRI/2012/10/003054 and how are they managed?
How do combination therapies involving micronutrient supplementation compare to monotherapies in the treatment of uncomplicated SAM as evaluated in CTRI/2012/10/003054?